#trial vaccines

[jangillman]

View this post on Instagram

A post shared by ⭐️ Sylvia | Daughter of Liberty (@simplipolish)

[chawsl]

Trial of twitter files.

[awesomecooperlove]

DEADLY V🧛🏿‍♂️A🧛🏿‍♂️C🧛🏿‍♂️C🧛🏿‍♂️I🧛🏿‍♂️N🧛🏿‍♂️E 🧛🏿‍♂️TRIALS🧛🏿‍♂️

🧟‍♀️🧛🏿‍♂️

[arctic-hands]

I wish I didn't have to be "otherwise healthy" to be in scientific trials and such. Like I get they need consistent variables, but also these drugs will go to treat people with health issues and very few chronically ill people have JUST ONE chronically illness so at some point in the trial they should be looking for people like me

[wumblr]

it's the third actually. rip china and cuba i don't know how they got jettisoned to space

[timothylawrence]

“This summer is about to be a movie!!!” forgot to clarify I didn’t want the movie to be in the horror genre

[gumjrop]

The Weather

As of September 13, 2024, national wastewater levels remain high. The CDC’s national wastewater map has contracted viral activity levels from ten grades of color to five grades of color while our map below maintains the original ten grades of color based on CDC data. We will adjust to the five grades in future reports. With schools in full session and the weather transitioning in northern regions to cooler temperatures, transmission continues to occur. Wastewater activity is either “High” or “Very High” in 37 states according to the Wastewater Surveillance System (NWSS) dashboard. Activity is “Moderate” in 8 states and the District of Columbia, and there is no data available for New Hampshire, North Dakota, Oregon, the U.S. Virgin Islands, and Guam. 

According to the Wastewater COVID-19 National and Regional Trends dashboard, COVID wastewater levels have plateaued, remaining between high and very high in all regions except for the West, which is having a slight increase. The highest levels remain in the West as of 9/7/2024 (data captured on 9/13/2024). 

In order to access local COVID wastewater levels, you can refer to the CDC’s state/territory trends page as well as the WastewaterSCAN dashboard. State and local public health wastewater trackers may also be available for example in Illinois, they are reporting over 80 locations. Also, the National Academies of Medicine recently published a second report stressing the importance of a robust wastewater surveillance system and its invaluable role in infectious disease surveillance. They recommend improving the consistency and quality of wastewater surveillance for COVID and other infectious diseases.

As of September 10, 2024, COVID levels are “likely growing” in 3 states and territories according to the CDC Center for Forecasting and Outbreak Analytics dashboard. Thirteen states have reached “stable or uncertain” levels, and 31 states are seeing “declining” or “likely declining”, while levels are “not estimated” in 4 states. 

Note, this model utilizes emergency department visit data to estimate COVID transmission’s Rt, which is an estimate of the average number of new infections caused by each infectious person. An Rt greater than 1.0 indicates that infections are growing, while an Rt less than 1.0 indicates that they’re declining.

According to the CDC's COVID Data Tracker, there has been an increase to nearly 1,000 deaths and slightly more than 1,000 deaths per week from COVID during the entire month of August 2024. The last time this occurred was during the winter months of 2024. This total count of weekly COVID deaths is likely to be an underestimate due to limited COVID testing and reporting. The loss of these lives could have been prevented if layers of protections were consistently implemented in preventing infections. 

A recent study published in the Annals of Internal Medicine highlights the importance of preventing infections especially during periods of high rates of transmission. It notes that COVID death rates were higher when healthcare systems faced a larger strain as a result of increased levels of transmission. Comprehensive policies that protect people and prevent healthcare-acquired COVID infections are needed to prevent healthcare system overload.

Variants

According to the CDC’s variant tracking dashboard, KP.3.1.1 remains the dominant variant of all currently circulating strains. Nowcast modeling projects that KP.3.1.1 will increase to 52.7% by 9/14/2024, followed by KP.2.3 at 12.2%, followed by LB.1 at 10.9%, and KP.3 at 10.6%, respectively. The most prevalent circulating variants are JN.1-derived, and closely related to both JN.1 and KP.2. Updated vaccination with any of the available options (Pfizer, Moderna, or Novavax) is recommended to better match current variants.

Vaccines and Treatment

Although the Bridge Access Program, covering the updated vaccines for uninsured and underinsured adults, has ended, several states including California’s Bridge Access Program and other departments of health have taken steps to partially address this major gap by either providing funding for no-cost access to COVID vaccines or using budgets to acquire a limited supply for their residents. Ultimately, the federal government must contribute resources to ensure no-cost access for all who are uninsured or underinsured. We continue to demand from the federal government to provide continued funding for the Bridge Access Program as well as the Vaccines for Adults Program. As people access the updated COVID vaccines, it is notable that a longer 1.5 inch needle may be needed for adults with higher body weights, in order to pass through subcutaneous tissue into muscle. Complete guidelines for vaccine administration in consideration of age, weight, and injection site can be found on the CDC's website.

It is important to seek treatment when facing a COVID infection. A recent study, reviewing population data of nonhospitalized individuals ages 18 and older during the period of January 2022 and December 2023, showed that nirmatrelvir/ritonavir (Paxlovid)—treatment for COVID—was less commonly used among those who identified as non-Hispanic Black and Latinx/e patients. Although the Test-to-Treat program prematurely ended, there continue to be programs available to ensure financial access to Paxlovid.

Wins

This is a reminder that another batch of no-cost COVID rapid antigen tests can be ordered and sent to your home address at the end of September 2024. Through the CDC’s Increasing Community Access to Testing (ICATT) program, no-cost access to COVID testing access is limited to those who are uninsured or underinsured at places including CVS, Walgreens, eTrueNorth, and other local sites as well as in New York City, which is supported by the NY Department of Public Health.

We are eagerly awaiting news on updates from the Centers for Medicare and Medicaid on mandatory reporting of COVID infections in healthcare systems, which begins November 1 thanks to our community’s advocacy. It is invaluable that all healthcare systems participate as case data is paramount for keeping track with current COVID trends and understanding the volume of healthcare acquired COVID infections. 

Take Action

The National Institute of Health (NIH) is seeking public comment and feedback on the next phase of RECOVER clinical trials, which focus on Long COVID. Meetings will be held virtually and on-site between September 23 and 25 to solicit feedback and comments. Register to attend these virtual or on-site sessions by September 25, 2024. It is very important to participate and ask NIH to commit to studies that will result in developing a better understanding of Long COVID, effective treatments for Long COVID, and key approaches to preventing Long COVID. 

Amid ongoing COVID spread, masking in healthcare remains central to safe access to healthcare. As we await implementation of COVID hospitalization reporting and prepare for CDC’s next Healthcare Infection Control Practices Advisory Committee meeting in November, you can use this letter campaign to ask your elected officials to take action for healthcare masking.

And finally, because all of us need access to the updated COVID vaccines regardless of our insurance status or ability to pay, use our letter template to demand free COVID vaccines for uninsured and underinsured adults nationally.

[17gz]

finding out my racist ass animation professor storyboarded season 5 of venture bros..... (the same professor that belittled and screamed at me for 45 mins IN APRIL 2021 when our class was ONLINE and I DIDNT HAVE ACCESS TO THE LABS and I WAS GOING THROUGH MUTIPLE PHYSICAL AND MENTAL HEALTH CRISES MID PANDEMIC. and told me i would be blacklisted for my struggles and i should just drop out and give up. and then i found out he only gave this talk to his asian students. he was always compassionate to his white students. SAME TEACHER I HAD TO EMAIL ON THE FIRST DAY OF CLASS BECAUSE HE SAID THE PHRASE "are you out of your cotton picking minds" AND I WAS LIKE HEY YOU CANT SAY THAT. and then he emailed me a COMPLETELY UNRELATED 5 paragraph thing about how hard pronouns are for him bc hes an old white guy. i didnt even mention my pronouns. he just emailed that in response to the email i sent abt him saying smth racist...)

[syekick-powers]

every single goddamn day of my life I pray that the fucking nasal covid vaccine that's still in development pans out with the level of effectiveness in humans that it showed in animal trials and that similar technology is used to develop nasal vaccines for things like the cold and flu because i am so so tired of wearing masks everywhere. literally unbelievably unconscionably tired. nobody else is doing it so any time im out in public i stick out like a sore thumb and my shit ass lung capacity means that wearing a mask for longer than about an hour will in fact cause me to struggle to get enough oxygen. i want to get a membership at a local gym and work out in a setting that i actually enjoy again but i literally cannot imagine working out in a mask without passing out eventually, let alone being able to get enough water when i cannot lower my mask around others. i want to go to concerts and movies and other public events again without having anxiety that my mom's gonna fucking die if i bring home covid or that im going to catch covid myself and develop even worse fatigue than i already have or parosmia so that all food tastes disgusting for the rest of my life or get even worse autoimmune problems than i already have. please. if that shit can stop covid with a 99% effectiveness i will kiss the feet of whoever developed it as long as it means not having to wear a goddamn mask in public again. im desperate. im so fucking desperate. if i have to wear masks in public for the entire rest of my adult life i am going to go absolutely bonkers fucking yonkers.

[supercantaloupe]

trying hard to avoid the kitten this week cause i have to be off my allergy meds until thursday

[jangillman]

Check it out

[toastsnaffler]

forgot I signed up for NHS vaccine trials on my uni account but I'm still getting emails sent to my alumni acc lol. anyway should I take £3500 to let them give me a trial vaccine slash placebo and infect me with live salmonella..... 🫣

[awesomecooperlove]

👶🏻💉👶🏼

[bbcphile]

You eat gluten free dumplings??? Tell me your secrets I beg you!! (No fr I want to try them so bad but can't :/)

Feel Good Foods has a few flavors of gluten free potstickers that are pretty great (at least, great compared with either no dumplings or agonizing pain from dumplings with gluten): https://feel-good-foods.com/product/chicken-dumplings/

Other than that, there’s one local restaurant near me that does actual gluten free har gow (all the other local places add wheat flour 😭).

Tragically, the only all-gluten-free Chinese restaurant near me closed down this summer (and I only learned about them three days before they closed!). The former owner said she might be publishing a cookbook, so if she ever does, I will definitely send you a link to it!

[4kadhd]

always a little sus about anything medical related needing my race esp with me being black

[rightnewshindi]

चीन के ड्रग रेगुलेटर ने MPox वैक्सीन के क्लिनिकल ट्रायल को दी मंजूरी, दवा फर्म सिनोफार्मा ने की है विकसित

चीन के ड्रग रेगुलेटर ने MPox वैक्सीन के क्लिनिकल ट्रायल को दी मंजूरी, दवा फर्म सिनोफार्मा ने की है विकसित #MPox #Vaccine #News #RightNewsIndia #RightNews

MPox Vaccine: ड्रग रेगुलेटर ने MPox वैक्सीन को क्लिनिकल ट्रायल की मंजूरी दे दी है. चाइना की स्थानीय दवा फर्म सिनोफार्मा द्वारा विकसित इस वैक्सीन को शीर्ष दवा नियामक ने क्लिनिकल ट्रायल की मंजूरी दी है. जो इस घातक बीमारी से लड़ने के लिए देश की पहली एक्सपेरिमेंटल डोज होगी. कंपनी ने सोमवार दोपहर को जारी किए बयान में कहा कि शंघाई इंस्टीट्यूट ऑफ बायोलॉजिकल प्रोडक्ट्स द्वारा निर्मित और सिनोफार्मा…